臺灣博碩士論文加值系統

TGF-β調控許多生理功能，例如細胞生長、細胞凋亡、細胞分化及細胞外間質 (ECM) 之合成等。CTGF為TGF-β 所調控之基因，可調節ECM相關蛋白之表現。雖然已有研究指出TNF-α可抑制TGF-β引發之CTGF表現，但詳細機轉仍不清楚。本論文發現，在WT MEF細胞，TNF-α可抑制TGF-β引發之CTGF表現，而此抑制作用在p65-/- MEF細胞消失，表示p65扮演重要角色。長時間 (8小時) 處理TNF-α可增加抑制性Smad之Smad7的表現，且阻斷Smad2之磷酸化而抑制TGF-β之signaling，在p65-/- MEF細胞，TNF-α無法引發Smad7之表現，亦不抑制Smad2之磷酸化；短時間 (1小時) 處理TNF-α可活化NF-κB signaling，使p65入核與Smad4競爭p300，造成Smad複合體與CTGF promoter結合時無法吸引p300，因而降低CTGF之表現。因此TNF-α是透過這兩種機制抑制TGF-β所引發之CTGF表現。

TGF-β regulates diverse biologic effects including cell growth, cell death or apoptosis, cell differentiation, and extracellular matrix (ECM) synthesis. Connective tissue growth factor (CTGF), which is induced by TGF-β, has been reported to mediate stimulatory action of TGF-β-induced ECM. Although TNF-α was reported to suppress the TGF-β-induced CTGF gene expression, the molecular mechanism is not well- clarified. In this study, we found the inhibitory effect of TNF-α on TGF-β-induced CTGF expression in WT MEF cells, and the attenuation was abrogated in p65-/- MEF cells, suggesting the role of p65 in TNF-α-mediated inhibition. Long-term (8 hours) treatment of TNF-α induced the expression of inhibitory Smad (Smad7) and the inhibition of TGF-β-induced Smad2 phosphorylation, thereby inhibiting TGF-β signaling which were not seen in p65-/- MEF cells. Short-term (1 hours) treatment of TNF-α activated NF-κB, and p65 preferentially interacted with p300, thereby disrupting TGF-β-induced interaction of Smad4 with p300 on the CTGF promoter. Two molecular mechanisms of TNF-α inhibition are explored. One is the induction of Smad7 expression, and the other is the switch of binding preference of p300 from Smad4 to p65, thereby leading to the inhibition of TGF-β-induced CTGF expression.

縮寫表……………………………………………………………………1
(Abbreviation)

中文摘要…………………………………………………………………4
(Abstract in Chinese)

英文摘要…………………………………………………………………5
(Abstract in English)

緒論………………………………………………………………………6
(Introduction)

實驗材料與方法…………………………………………………………31
(Materials and Methods)

結果………………………………………………………………………40
(Results)

討論………………………………………………………………………61
(Discussion)

參考文獻…………………………………………………………………65
(References)

Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y and Leask A (2000) Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 275(20):15220-15225.
Abreu JG, Ketpura NI, Reversade B and De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4(8):599-604.
Adamson AL and Kenney S (2001) Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75(5):2388-2399.
Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G, Hong SM, Mullendore M, Roa I, Ibanez L, Pimentel F, Diaz A, Riggins GJ and Maitra A (2008) Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res 14(9):2631-2638.
Ayaydin F and Dasso M (2004) Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 15(12):5208-5218.
Babic AM, Chen CC and Lau LF (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19(4):2958-2966.
Ball DK, Rachfal AW, Kemper SA and Brigstock DR (2003) The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol 176(2):R1-7.
Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC and Varga J (2005) Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Arthritis Rheum 52(4):1248-1258.
Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M and Bottinger EP (2000) A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev 14(2):187-197.
Blobe GC, Schiemann WP and Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342(18):1350-1358.
Bradham DM, Igarashi A, Potter RL and Grotendorst GR (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114(6):1285-1294.
Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR and Harding PA (1997) Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272(32):20275-20282.
Burgess JK (2005) Connective tissue growth factor: a role in airway remodelling in asthma? Clin Exp Pharmacol Physiol 32(11):988-994.
Burgess JK, Ge Q, Poniris MH, Boustany S, Twigg SM, Black JL and Johnson PR (2006) Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. Am J Physiol 290(1):L153-161.
Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP and Lin K (2001) The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat Struct Biol 8(3):248-253.
Chan HM and La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114(Pt 13):2363-2373.
Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R and Massague J (1987) The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48(3):409-415.
Chen CC, Chen N and Lau LF (2001) The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276(13):10443-10452.
Chen CR, Kang Y, Siegel PM and Massague J (2002) E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110(1):19-32.
Courtois G and Israel A (2000) NF-kappa B defects in humans: the NEMO/ incontinentia pigmenti connection. Sci STKE 2000(58):PE1.
Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S and Gauthier JM (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J 17(11):3091-3100.
Derynck R, Gelbart WM, Harland RM, Heldin CH, Kern SE, Massague J, Melton DA, Mlodzik M, Padgett RW, Roberts AB, Smith J, Thomsen GH, Vogelstein B and Wang XF (1996) Nomenclature: vertebrate mediators of TGFbeta family signals. Cell 87(2):173.
Derynck R and Miyazono Ko (2007) The TGF-[beta] family. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Derynck R, Zhang Y and Feng XH (1998) Smads: transcriptional activators of TGF-beta responses. Cell 95(6):737-740.
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388(6642):548-554.
Dooley S, Said HM, Gressner AM, Floege J, En-Nia A and Mertens PR (2006) Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281(3):1784-1795.
Eigler A, Sinha B, Hartmann G and Endres S (1997) Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 18(10):487-492.
Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH and Miyazono K (1993) Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75(4):681-692.
Germain S, Howell M, Esslemont GM and Hill CS (2000) Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev 14(4):435-451.
Ghosh AK (2002) Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med 227(5):301-314.
Ghosh AK and Varga J (2007) The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol 213(3):663-671.
Ghosh AK, Yuan W, Mori Y, Chen S and Varga J (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 276(14):11041-11048.
Ghosh S, May MJ and Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
Gilmore TD (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25(51):6680-6684.
Goumans MJ and Mummery C (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44 (3):253-265.
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271(5247): 350-353.
Hata A, Lagna G, Massague J and Hemmati-Brivanlou A (1998) Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12(2):186-197.
Hata A, Lo RS, Wotton D, Lagna G and Massague J (1997) Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388 (6637):82-87.
Hayden MS and Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18(18): 2195-2224.
Heldin C-H, Miyazono K and ten Dijke P (1997) TGF-[beta] signalling from cell membrane to nucleus through SMAD proteins. Nature 390(6659):465-471.
Holmes A, Abraham DJ, Chen Y, Denton C, Shi-wen X, Black CM and Leask A (2003) Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem 278(43):41728-41733.
Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM and Leask A (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276(14):10594-10601.
Hsu H, Shu HB, Pan MG and Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84(2):299-308.
Huang SS and Huang JS (2005) TGF-beta control of cell proliferation. J Cell Biochem 96(3):447-462.
Huang WC, Ju TK, Hung MC and Chen CC (2007) Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 26(1):75-87.
Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M and Miyazono K (1997) Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389 (6651):622-626.
Ito T, Ikehara T, Nakagawa T, Kraus WL and Muramatsu M (2000) p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone. Genes Dev 14(15):1899-1907.
Itoh S, Itoh F, Goumans MJ and Ten Dijke P (2000) Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 267(24): 6954-6967.
Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A and Lyons KM (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130(12): 2779-2791.
Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF and Lam SC (1999) Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 274(34):24321-24327.
Joan Massagué aDW (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19(8):1745-1754.
Jonk LJ, Itoh S, Heldin CH, ten Dijke P and Kruijer W (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273(33):21145-21152.
Karin M (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18(49):6867-6874.
Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6(6):1365-1375.
Kim JH, Cho EJ, Kim ST and Youn HD (2005) CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain. Nat Struct Mol Biol 12(5):423-428.
Kim KH, Park GT, Lim YB, Rue SW, Jung JC, Sonn JK, Bae YS, Park JW and Lee YS (2004) Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. Biochem Biophys Res Commun 318 (4):819-825.
Kim RH, Flanders KC, Birkey Reffey S, Anderson LA, Duckett CS, Perkins ND and Roberts AB (2001) SNIP1 inhibits NF-kappa B signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional co-activators. J Biol Chem 276(49):46297-46304.
Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, Parks WT, Meng X, Lechleider RJ, Wang T and Roberts AB (2000) A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev 14(13):1605-1616.
Kon A, Vindevoghel L, Kouba DJ, Fujimura Y, Uitto J and Mauviel A (1999) Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression. Oncogene 18(10):1837-1844.
Kucich U, Rosenbloom JC, Herrick DJ, Abrams WR, Hamilton AD, Sebti SM and Rosenbloom J (2001) Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys 395(1):103-112.
Larco JED and Todaro GJ (1978) Growth Factors from Murine Sarcoma Virus-Transformed Cells. Proc Natl Acad Sci U S A 75(8):4001-4005.
Lau LF and Lam SC (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248(1):44-57.
Leask A and Abraham DJ (2003) The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81(6):355-363.
Leask A, Holmes A, Black CM and Abraham DJ (2003) Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278(15):13008-13015.
Lee CH, Jeon YT, Kim SH and Song YS (2007) NF-kappaB as a potential molecular target for cancer therapy. BioFactors 29(1):19-35.
Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM and Massague J (1996) A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381(6583):620-623.
Liu X, Yue J, Frey RS, Zhu Q and Mulder KM (1998) Transforming growth factor beta signaling through Smad1 in human breast cancer cells. Cancer Res 58(20): 4752-4757.
Luft FC (2008) CCN2, the connective tissue growth factor. J Mol Med 86(1):1-3.
Malek S, Chen Y, Huxford T and Ghosh G (2001) IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. J Biol Chem 276(48):45225-45235.
Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
Massague J and Wotton D (2000) Transcriptional control by the TGF-beta/Smad signaling system. Embo J 19(8):1745-1754.
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A and Rao A (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278(5339):860-866.
Nagarajan RP, Zhang J, Li W and Chen Y (1999) Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem 274(47):33412-33418.
Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH and ten Dijke P (1997a) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 (6651):631-635.
Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K and ten Dijke P (1997b) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J 16 (17):5353-5362.
Pannu J and Trojanowska M (2004) Recent advances in fibroblast signaling and biology in scleroderma. Curr Opin Rheumatol 16(6):739-745.
Partanen A, Motoyama J and Hui CC (1999) Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int J Dev Biol 43(6):487-494.
Peters RT and Maniatis T (2001) A new family of IKK-related kinases may function as I kappa B kinase kinases. Biochim Biophys Acta 1471(2):M57-62.
Piek E, Heldin CH and Ten Dijke P (1999) Specificity, diversity, and regulation in TGF-beta superfamily signaling. Faseb J 13(15):2105-2124.
Raftery LA, Twombly V, Wharton K and Gelbart WM (1995) Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 139(1):241-254.
Rahimi RA and Leof EB (2007) TGF-beta signaling: a tale of two responses. J Cell Biochem 102(3):593-608.
Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z and Rothe M (1997) Identification and characterization of an IkappaB kinase. Cell 90(2):373-383.
Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Eelectrolyte Metab 24(2-3):111-119.
Sakurai H, Chiba H, Miyoshi H, Sugita T and Toriumi W (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274(43):30353-30356.
Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE and Padgett RW (1996) Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. Proc Natl Acad Sci U S A 93(2):790-794.
Scheidereit C (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25(51):6685-6705.
Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR, 3rd and Carmichael DF (2001) The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276(44): 40659-40667.
Shi Y and Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685-700.
Shikama N, Lutz W, Kretzschmar R, Sauter N, Roth JF, Marino S, Wittwer J, Scheidweiler A and Eckner R (2003) Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. Embo J 22(19):5175-5185.
Solis-Herruzo JA, Brenner DA and Chojkier M (1988) Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem 263(12):5841-5845.
Souchelnytskyi S, ten Dijke P, Miyazono K and Heldin CH (1996) Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses. Embo J 15(22):6231-6240.
Stratton R, Rajkumar V, Ponticos M, Nichols B, Shiwen X, Black CM, Abraham DJ and Leask A (2002) Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway. Faseb J 16(14):1949-1951.
Suganuma T, Kawabata M, Ohshima T and Ikeda MA (2002) Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator. Proc Natl Acad Sci U S A 99(20):13073-13078.
Szlosarek PW and Balkwill FR (2003) Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol 4(9):565-573.
Van Beek JP, Kennedy L, Rockel JS, Bernier SM and Leask A (2006) The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther 8(2):R36.
Varga J and Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117(3):557-567.
Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411-452.
Verrecchia F, Pessah M, Atfi A and Mauviel A (2000) Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem 275(39):30226-30231.
Vo N and Goodman RH (2001) CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276(17):13505-13508.
Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R and Mark DF (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228(4696):149-154.
Whitman M (1998) Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev 12(16):2445-2462.
Wong C, Rougier-Chapman EM, Frederick JP, Datto MB, Liberati NT, Li JM and Wang XF (1999) Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol 19(3):1821-1830.
Wrana JL, Attisano L, Wieser R, Ventura F and Massague J (1994) Mechanism of activation of the TGF-beta receptor. Nature 370(6488):341-347.
Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, Hoshino K, Kaisho T, Kuwata H, Takeuchi O, Takeshige K, Saitoh T, Yamaoka S, Yamamoto N, Yamamoto S, Muta T, Takeda K and Akira S (2004) Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430(6996):218-222.
Yamamoto Y, Verma UN, Prajapati S, Kwak YT and Gaynor RB (2003) Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423(6940):655-659.
Yao TP, Oh SP, Fuchs M, Zhou ND, Ch''ng LE, Newsome D, Bronson RT, Li E, Livingston DM and Eckner R (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93(3):361-372.
Yeger H and Perbal B (2007) The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal 1(3-4):159-164.
Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT and Wang XF (1997) Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol 17(12):7019-7028.
Zandi E, Rothwarf DM, Delhase M, Hayakawa M and Karin M (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91(2): 243-252.
Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B and Kern SE (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1(4):611-617.
Zhang Y, Feng X, We R and Derynck R (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383(6596):168-172.
Zhu F, Xia X, Liu B, Shen J, Hu Y, Person M and Hu Y (2007) IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Mol Cell 27(2):214-227.